Experts warn against mixing vaccine doses as Moderna, J&J recipients await FDA booster decision

Some Americans who received COVID-19 vaccines made by Moderna or Pfizer have sought additional Pfizer shots, a move physicians are advising against, Tampa, Fla.-based ABC affiliate WFTS-TV reported Oct. 11.

Advertisement

Because Americans usually don’t have to present medical paperwork to get a COVID-19 vaccine, some who have been fully vaccinated are pretending to receive initial vaccinations from a different drugmaker, either because they are worried their vaccination isn’t providing strong enough protection or they feel left in the dark about when they will be eligible for a booster.

However, physicians and public health experts are warning against mixing COVID-19 doses, as there is no safety or efficacy data on the practice.

“The biggest concern of course is that we never studied that and so there’s no indication that if you get the Moderna shot, you’re going to boost what Pfizer already did. And so essentially instead of acting like a booster, it acts like a different shot. Almost as if you got vaccinated by something different,” Jill Roberts, PhD, an epidemiology professor at the University of South Florida in Tampa, told the station.

Mixing doses also makes it difficult for researchers to track vaccination data accurately, Dr. Roberts said.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, TRC Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.